In this kickoff episode of Designing Through Disruption, Christopher Montalbano, CEO of MIDI Medical Product Development, explores how medical device teams can integrate a resilient, forward-thinking approach into their product development strategies, especially in the face of global uncertainty (tariffs).

Chris introduces listeners to MIDI’s DevelopmentDNA™ process and explains how their firm has evolved to embed advanced Design for Excellence (DFX) strategies early in the development cycle. These methods, initially honed during the COVID-era supply chain crisis, are now proving indispensable as global tariffs and component shortages continue to challenge the industry.

Key takeaways from this episode include:

What DFX really means—and why it should never be an afterthought

The strategic advantage of Concurrent Engineering over traditional development models

How to align advanced development methodologies with ISO-13485 and FDA design control guidance

The role of MIDI’s Innovation Roadmap™ in mitigating risk and accelerating time to market

This episode lays the foundation for a series focused on strengthening medical device development pipelines, making them compliant and competitively agile.

Next, we’ll explore the supply chain conundrum further and share our Advanced DFX Strategy for design-for-supply-chain integration.